144 related articles for article (PubMed ID: 28989042)
21. Identification of Hub Genes and Key Pathways Associated with Anti-
Arya KR; Bharath Chand RP; Abhinand CS; Nair AS; Oommen OV; Sudhakaran PR
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803224
[TBL] [Abstract][Full Text] [Related]
22. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
23.
Deng Y; Ma H; Hao J; Xie Q; Zhao R
Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
[TBL] [Abstract][Full Text] [Related]
24. Primary glioblastoma transcriptome data analysis for screening survival-related genes.
Yang Y; Yan R; Zhang L; Meng X; Sun W
J Cell Biochem; 2020 Feb; 121(2):1901-1910. PubMed ID: 31633244
[TBL] [Abstract][Full Text] [Related]
25. Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma.
Li S; Sun X; Miao S; Liu J; Jiao W
Thorac Cancer; 2017 Nov; 8(6):672-681. PubMed ID: 28949095
[TBL] [Abstract][Full Text] [Related]
26. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
[TBL] [Abstract][Full Text] [Related]
27. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
Xiong DD; Xu WQ; He RQ; Dang YW; Chen G; Luo DZ
Oncol Rep; 2019 Apr; 41(4):2194-2208. PubMed ID: 30816530
[TBL] [Abstract][Full Text] [Related]
28. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
29. Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.
Wu B; Jiang S; Wang X; Zhong S; Bi Y; Yi D; Liu G; Hu F; Dou G; Chen Y; Wu Y; Dong J
PLoS One; 2020; 15(10):e0240230. PubMed ID: 33119597
[TBL] [Abstract][Full Text] [Related]
30. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
31. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract][Full Text] [Related]
32. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
[TBL] [Abstract][Full Text] [Related]
34. Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
Xu L; Tong T; Wang Z; Qiang Y; Ma F; Ma X
Am J Med Sci; 2020 Apr; 359(4):226-234. PubMed ID: 32200915
[TBL] [Abstract][Full Text] [Related]
35. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
36. The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells.
Zumbar CT; Usubalieva A; King PD; Li X; Mifsud CS; Dalton HM; Sak M; Urio S; Bryant WM; McElroy JP; Farmer G; Lehman NL
J Neurooncol; 2018 May; 137(3):481-492. PubMed ID: 29396807
[TBL] [Abstract][Full Text] [Related]
37. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
Liao YX; Zhang ZP; Zhao J; Liu JP
Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
[TBL] [Abstract][Full Text] [Related]
39. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
40. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]